These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 18756933)

  • 1. [Arsenic trioxide combined with buthionine sulfoximine enhances apoptosis in multidrug-resistant human leukemia K562/ADM cells in vitro].
    Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):188-91. PubMed ID: 18756933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of arsenic trioxide (As2O3) combined with BSO on K562/ADM cell and its mechanisms].
    Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):438-43. PubMed ID: 18072624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide circumvents multidrug resistance based on different mechanisms in human leukemia cell lines.
    Seo T; Urasaki Y; Takemura H; Ueda T
    Anticancer Res; 2005; 25(2A):991-8. PubMed ID: 15868938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
    Wu XX; Ogawa O; Kakehi Y
    Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arsenic trioxide inhibits P-glycoprotein expression in multidrug-resistant human leukemia K562/ADM cell line that overexpresses mdr-1 gene and enhances their chemotherapeutic sensitivity].
    Wei HL; Yao XJ; Li YN; Wang P; Zhao HS; Bai DC; Peng X; Ma LF
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jan; 24(1):28-31. PubMed ID: 12679007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine.
    Maeda H; Hori S; Ohizumi H; Segawa T; Kakehi Y; Ogawa O; Kakizuka A
    Cell Death Differ; 2004 Jul; 11(7):737-46. PubMed ID: 15002036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the resveratrol and arsenic trioxide combination induced apoptosis and its mechanism on lung adenocarcinoma cells].
    Gu S; Chen C; Jiang X; Zhang Z
    Wei Sheng Yan Jiu; 2016 Jan; 45(1):87-92. PubMed ID: 26987203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro effect of bortezomib alone or in combination with harringtonine or arsenic trioxide on proliferation and apoptosis of multidrug resistant leukemia cells].
    Cai YX; Meng FY; Sun QX; Fu YB; Li L
    Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):737-40. PubMed ID: 19176009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Apoptosis of MR2 cells induced by Tanshinone II A combined with arsenic trioxide].
    Li L; Zhang ZH; Zhao WD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):812-6. PubMed ID: 19950589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptors.
    Chen D; Chan R; Waxman S; Jing Y
    Cancer Res; 2006 Dec; 66(23):11416-23. PubMed ID: 17145888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glutathione synthesis inhibitor enhances arsenic trioxide-induced apoptosis].
    Shen Y; Chen G; Cai X
    Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):259-61. PubMed ID: 11776809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential augmentative effects of buthionine sulfoximine and ascorbic acid in As2O3-induced ovarian cancer cell death: oxidative stress-independent and -dependent cytotoxic potentiation.
    Ong PS; Chan SY; Ho PC
    Int J Oncol; 2011 Jun; 38(6):1731-9. PubMed ID: 21455570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of arsenic trioxide combined with adriamycin on the proliferation and apoptosis of human lymphoma cells].
    Huang R; Li X; Huang X; Yang X; Li W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 34(6):515-22. PubMed ID: 19587434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells.
    Yang CH; Kuo ML; Chen JC; Chen YC
    Br J Cancer; 1999 Nov; 81(5):796-9. PubMed ID: 10555748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis in arsenic trioxide-treated lung cancer A549 cells by buthionine sulfoximine.
    Han YH; Kim SZ; Kim SH; Park WH
    Mol Cells; 2008 Aug; 26(2):158-64. PubMed ID: 18596414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system.
    Lösler S; Schlief S; Kneifel C; Thiel E; Schrezenmeier H; Rojewski MT
    Ann Hematol; 2009 Nov; 88(11):1047-58. PubMed ID: 19301004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system.
    Dai J; Weinberg RS; Waxman S; Jing Y
    Blood; 1999 Jan; 93(1):268-77. PubMed ID: 9864170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression and response to arsenic stress of MRPs and ASAN1 determine sensitivity of classical multidrug-resistant leukemia cells to arsenic trioxide.
    Chen J; Cheng J; Yi J; Xie B; Lin L; Liu Z; Zhao H; Wang B; Ai Z; Yang Y; Wei H
    Leuk Res; 2016 Nov; 50():116-122. PubMed ID: 27736728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal effect of arsenic sensitivity in human leukemia cell line K562 and K562/ADM using realgar transforming solution.
    Wang X; Zhang X; Xu Z; Wang Z; Yue X; Li H
    Biol Pharm Bull; 2013; 36(4):641-8. PubMed ID: 23358330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
    Kito M; Akao Y; Ohishi N; Yagi K; Nozawa Y
    Biochem Biophys Res Commun; 2002 Mar; 291(4):861-7. PubMed ID: 11866444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.